Stock Ratios
Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.
profit margin TTM
-29183.93%
operating margin TTM
-25373.81%
revenue TTM
N/A
revenue per share TTM
0.0$
valuation ratios | |
|---|---|
| pe ratio | -3.40 |
| peg ratio | -0.16 |
| price to book ratio | 14.20 |
| price to sales ratio | 1,183.23 |
| enterprise value multiple | -4.02 |
| price fair value | 14.20 |
profitability ratios | |
|---|---|
| gross profit margin | -41.07% |
| operating profit margin | -25373.81% |
| pretax profit margin | -29104.17% |
| net profit margin | -29183.93% |
| return on assets | -41.83% |
| return on equity | -186.08% |
| return on capital employed | -38.84% |
liquidity ratios | |
|---|---|
| current ratio | 5.00 |
| quick ratio | 5.00 |
| cash ratio | 2.25 |
efficiency ratios | |
|---|---|
| days of inventory outstanding | 0.00 |
| operating cycle | 0.00 |
| days of payables outstanding | 2,709.01 |
| cash conversion cycle | -2,709.01 |
| receivables turnover | 0.00 |
| payables turnover | 0.13 |
| inventory turnover | 0.00 |
debt and solvency ratios | |
|---|---|
| debt ratio | 0.15 |
| debt equity ratio | 1.48 |
| long term debt to capitalization | 0.60 |
| total debt to capitalization | 0.60 |
| interest coverage | 0.00 |
| cash flow to debt ratio | -1.69 |
cash flow ratios | |
|---|---|
| free cash flow per share | -0.64 |
| cash per share | 0.74 |
| operating cash flow per share | -0.63 |
| free cash flow operating cash flow ratio | 1.02 |
| cash flow coverage ratios | -1.69 |
| short term coverage ratios | 0.00 |
| capital expenditure coverage ratio | -49.22 |
Frequently Asked Questions
When was the last time Quince Therapeutics, Inc. (NASDAQ:QNCX) reported earnings?
Quince Therapeutics, Inc. (QNCX) published its most recent earnings results on 12-11-2025.
What is Quince Therapeutics, Inc.'s current ROE?
An investor's main concern is the profitability ratios of a company so that they are able to understand how it performs financially. Investors are interested in finding out how effectively a business is using their cash to produce earnings, which is why return on equity (ROE) ratio is important. Quince Therapeutics, Inc. (NASDAQ:QNCX)'s trailing twelve months ROE is -186.08%.
What are ROA telling us?
The Return on Assets (ROA) ratio measures how profitable a company is relative to its total assets. Quince Therapeutics, Inc. (QNCX) currently has a ROA of -41.83%. Companies that manage their assets effectively will have greater returns, while those that do so poorly would suffer lower returns.
Where did QNCX's net profit margin stand at?
QNCX reported a profit margin of -29183.93% in the last quarter. A company's profit margin, also known as its revenue ratio or gross profit ratio, reflects the amount of revenue that an organization earns compared to its net income. In general, a higher ratio implies greater profit, and vice versa.
What is QNCX's short-term liquidity position?
Apple's current ratio, which measures its ability to pay short-term obligations, was 5.00 in the most recent quarter. The quick ratio stood at 5.00, with a Debt/Eq ratio of 1.48.